PIMG
PLXP

Patriot Investment Management Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Patriot Investment Management Group’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$648 – 684
2020
Q2 		$648 Buy
+200
New +$604 ﹤0.01% 673

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
CWM
Cranbrook Wealth Management Bloomfield Hills, Michigan $492M AUM 14.37% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Patriot Investment Management Group's PLXP Position: Q3 2020 in Review

Patriot Investment Management Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2020, closing a stake of 200 shares — an estimated $648 sold.

Patriot Investment Management Group first reported a position in PLXP in Q2 2020 and held it in 1 quarter. The position peaked at $648 in Q2 2020. 15 funds tracked by Wall St. Rank hold PLXP as of Q3 2020.

  • Patriot Investment Management Group reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Patriot Investment Management Group sold 200 PLx Pharma Inc. Common Stock shares in Q3 2020, an estimated $648.
  • Patriot Investment Management Group first reported a position in PLx Pharma Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Patriot Investment Management Group's PLx Pharma Inc. Common Stock position peaked at $648 in Q2 2020.
  • 15 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2020.

Based on Patriot Investment Management Group's 13F filing for Q3 2020, filed 23 Oct 2020.